Impact of Coronavirus-2019 On Pediatric and Adult Heart Transplantation Waitlist Activity and Mortality in The United States: A Descriptive Approach

Background: Transplant centers saw a substantial reduction in deceased donor solid organ transplantation since the beginning of the coronavirus 2019 (COVID-19) pandemic in the United States. There is limited data on the impact of COVID-19 on adult and pediatric heart transplant volume and variation...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Awais Ashfaq, MD, Geoffrey M. Gray, PhD, Jennifer Carapellucci, Ernest K. Amankwah, PhD, Luis M. Ahumada, PhD, Mohamed Rehman, MD, Michael Puchalski, MD, Andrew Smith, MD, James A. Quintessenza, MD, Alfred Asante-Korang, MD
Formato: article
Lenguaje:EN
Publicado: Elsevier 2021
Materias:
Acceso en línea:https://doaj.org/article/1b0aba24f40143519743ce9ed3a781e1
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:1b0aba24f40143519743ce9ed3a781e1
record_format dspace
spelling oai:doaj.org-article:1b0aba24f40143519743ce9ed3a781e12021-11-12T04:50:27ZImpact of Coronavirus-2019 On Pediatric and Adult Heart Transplantation Waitlist Activity and Mortality in The United States: A Descriptive Approach2667-193X10.1016/j.lana.2021.100060https://doaj.org/article/1b0aba24f40143519743ce9ed3a781e12021-11-01T00:00:00Zhttp://www.sciencedirect.com/science/article/pii/S2667193X21000569https://doaj.org/toc/2667-193XBackground: Transplant centers saw a substantial reduction in deceased donor solid organ transplantation since the beginning of the coronavirus 2019 (COVID-19) pandemic in the United States. There is limited data on the impact of COVID-19 on adult and pediatric heart transplant volume and variation in transplant practices. We hypothesized that heart transplant activity decreased during COVID-19 with associated increased waitlist mortality. Methods: The United Network for Organ Sharing (UNOS) database was used to identify patients at the time of listing for heart transplant from 2017–2020. Patients were categorized as pediatric (<18 years) or adult (≥18 years) and as pre-COVID (2017-2019) or post-COVID (2020). Regional and statewide data were taken from United States Census Bureau. CovidActNow project was used to obtain COVID-19 mortality rates. Findings: Among pediatric patients, average time on the waiting list decreased by 28 days. Even though the average number of pediatric transplants (n=39 per month) did not change significantly during 2020, there was a temporal decline in the first quarter of 2020 followed by a sharp increase. Overall absolute pediatric waitlist mortality decreased from 5•31 to 4•73, however female mortality increased by 2%. Regional differences in pediatric mortality were observed: Northeast, decreased by 7•5%; Midwest, decreased by 9%; West, increased by 3•5%; and South, increased by 13%. North Dakota (0•55), Oklahoma (0•21) and Hawaii (0•33) showed higher mortality than other states per 100,000. In adults, average time on waiting list increased by 40 days and there was an increase in the number of transplants from 242 to 266. Adult waitlist mortality had a larger decrease, 18•44 to 15•70, with an increase in female mortality of 7%. Regional differences in adult mortality were also observed: Northeast, decreased by 3%; Midwest, increased by 5•5%; West, increased by 4•5% and South, decreased by 5%. Iowa (0•37), Wyoming (0•22), Arkansas (0•18) and Vermont (0•19) had the highest mortality per 100,000 compared to the other states. Interpretation: Pediatric heart transplant volume declined in early 2020 followed by a later increase, while adult transplant volume increased all year round. Although, overall pediatric waitlist mortality decreased, female waitlist mortality increased for both adults and pediatrics. Regional differences in waitlist mortality were observed for both pediatrics and adults. Future studies are needed to understand this initial correlation and to determine the impact of COVID-19 on heart transplant recipients Funding: This research received no specific grant from any funding agency in the public, commercial or not-for-profit sectors.Awais Ashfaq, MDGeoffrey M. Gray, PhDJennifer CarapellucciErnest K. Amankwah, PhDLuis M. Ahumada, PhDMohamed Rehman, MDMichael Puchalski, MDAndrew Smith, MDJames A. Quintessenza, MDAlfred Asante-Korang, MDElsevierarticleCOVID-19Heart transplantMortalityPandemicPolicyPublic aspects of medicineRA1-1270ENThe Lancet Regional Health. Americas, Vol 3, Iss , Pp 100060- (2021)
institution DOAJ
collection DOAJ
language EN
topic COVID-19
Heart transplant
Mortality
Pandemic
Policy
Public aspects of medicine
RA1-1270
spellingShingle COVID-19
Heart transplant
Mortality
Pandemic
Policy
Public aspects of medicine
RA1-1270
Awais Ashfaq, MD
Geoffrey M. Gray, PhD
Jennifer Carapellucci
Ernest K. Amankwah, PhD
Luis M. Ahumada, PhD
Mohamed Rehman, MD
Michael Puchalski, MD
Andrew Smith, MD
James A. Quintessenza, MD
Alfred Asante-Korang, MD
Impact of Coronavirus-2019 On Pediatric and Adult Heart Transplantation Waitlist Activity and Mortality in The United States: A Descriptive Approach
description Background: Transplant centers saw a substantial reduction in deceased donor solid organ transplantation since the beginning of the coronavirus 2019 (COVID-19) pandemic in the United States. There is limited data on the impact of COVID-19 on adult and pediatric heart transplant volume and variation in transplant practices. We hypothesized that heart transplant activity decreased during COVID-19 with associated increased waitlist mortality. Methods: The United Network for Organ Sharing (UNOS) database was used to identify patients at the time of listing for heart transplant from 2017–2020. Patients were categorized as pediatric (<18 years) or adult (≥18 years) and as pre-COVID (2017-2019) or post-COVID (2020). Regional and statewide data were taken from United States Census Bureau. CovidActNow project was used to obtain COVID-19 mortality rates. Findings: Among pediatric patients, average time on the waiting list decreased by 28 days. Even though the average number of pediatric transplants (n=39 per month) did not change significantly during 2020, there was a temporal decline in the first quarter of 2020 followed by a sharp increase. Overall absolute pediatric waitlist mortality decreased from 5•31 to 4•73, however female mortality increased by 2%. Regional differences in pediatric mortality were observed: Northeast, decreased by 7•5%; Midwest, decreased by 9%; West, increased by 3•5%; and South, increased by 13%. North Dakota (0•55), Oklahoma (0•21) and Hawaii (0•33) showed higher mortality than other states per 100,000. In adults, average time on waiting list increased by 40 days and there was an increase in the number of transplants from 242 to 266. Adult waitlist mortality had a larger decrease, 18•44 to 15•70, with an increase in female mortality of 7%. Regional differences in adult mortality were also observed: Northeast, decreased by 3%; Midwest, increased by 5•5%; West, increased by 4•5% and South, decreased by 5%. Iowa (0•37), Wyoming (0•22), Arkansas (0•18) and Vermont (0•19) had the highest mortality per 100,000 compared to the other states. Interpretation: Pediatric heart transplant volume declined in early 2020 followed by a later increase, while adult transplant volume increased all year round. Although, overall pediatric waitlist mortality decreased, female waitlist mortality increased for both adults and pediatrics. Regional differences in waitlist mortality were observed for both pediatrics and adults. Future studies are needed to understand this initial correlation and to determine the impact of COVID-19 on heart transplant recipients Funding: This research received no specific grant from any funding agency in the public, commercial or not-for-profit sectors.
format article
author Awais Ashfaq, MD
Geoffrey M. Gray, PhD
Jennifer Carapellucci
Ernest K. Amankwah, PhD
Luis M. Ahumada, PhD
Mohamed Rehman, MD
Michael Puchalski, MD
Andrew Smith, MD
James A. Quintessenza, MD
Alfred Asante-Korang, MD
author_facet Awais Ashfaq, MD
Geoffrey M. Gray, PhD
Jennifer Carapellucci
Ernest K. Amankwah, PhD
Luis M. Ahumada, PhD
Mohamed Rehman, MD
Michael Puchalski, MD
Andrew Smith, MD
James A. Quintessenza, MD
Alfred Asante-Korang, MD
author_sort Awais Ashfaq, MD
title Impact of Coronavirus-2019 On Pediatric and Adult Heart Transplantation Waitlist Activity and Mortality in The United States: A Descriptive Approach
title_short Impact of Coronavirus-2019 On Pediatric and Adult Heart Transplantation Waitlist Activity and Mortality in The United States: A Descriptive Approach
title_full Impact of Coronavirus-2019 On Pediatric and Adult Heart Transplantation Waitlist Activity and Mortality in The United States: A Descriptive Approach
title_fullStr Impact of Coronavirus-2019 On Pediatric and Adult Heart Transplantation Waitlist Activity and Mortality in The United States: A Descriptive Approach
title_full_unstemmed Impact of Coronavirus-2019 On Pediatric and Adult Heart Transplantation Waitlist Activity and Mortality in The United States: A Descriptive Approach
title_sort impact of coronavirus-2019 on pediatric and adult heart transplantation waitlist activity and mortality in the united states: a descriptive approach
publisher Elsevier
publishDate 2021
url https://doaj.org/article/1b0aba24f40143519743ce9ed3a781e1
work_keys_str_mv AT awaisashfaqmd impactofcoronavirus2019onpediatricandadulthearttransplantationwaitlistactivityandmortalityintheunitedstatesadescriptiveapproach
AT geoffreymgrayphd impactofcoronavirus2019onpediatricandadulthearttransplantationwaitlistactivityandmortalityintheunitedstatesadescriptiveapproach
AT jennifercarapellucci impactofcoronavirus2019onpediatricandadulthearttransplantationwaitlistactivityandmortalityintheunitedstatesadescriptiveapproach
AT ernestkamankwahphd impactofcoronavirus2019onpediatricandadulthearttransplantationwaitlistactivityandmortalityintheunitedstatesadescriptiveapproach
AT luismahumadaphd impactofcoronavirus2019onpediatricandadulthearttransplantationwaitlistactivityandmortalityintheunitedstatesadescriptiveapproach
AT mohamedrehmanmd impactofcoronavirus2019onpediatricandadulthearttransplantationwaitlistactivityandmortalityintheunitedstatesadescriptiveapproach
AT michaelpuchalskimd impactofcoronavirus2019onpediatricandadulthearttransplantationwaitlistactivityandmortalityintheunitedstatesadescriptiveapproach
AT andrewsmithmd impactofcoronavirus2019onpediatricandadulthearttransplantationwaitlistactivityandmortalityintheunitedstatesadescriptiveapproach
AT jamesaquintessenzamd impactofcoronavirus2019onpediatricandadulthearttransplantationwaitlistactivityandmortalityintheunitedstatesadescriptiveapproach
AT alfredasantekorangmd impactofcoronavirus2019onpediatricandadulthearttransplantationwaitlistactivityandmortalityintheunitedstatesadescriptiveapproach
_version_ 1718431154944606208